Abbott to acquire Latin American CFR Pharmaceuticals
Abbott will acquire the holding company that indirectly owns approximately 73 per cent of CFR Pharmaceuticals
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Merck Serono and Mersana to develop antibody-drug conjugates
Mersana and Merck Serono will leverage Mersana’s Fleximer technology to generate ADCs for multiple undisclosed targets
Arvind Remedies and Adesh University sign MOU
To launch new drugs for treating Type-II diabetes, depression and coronary heart diseases
IPM registers Rs 6636 crores in May 2014
11 therapies have outgrown the IPM growth and five therapies have double digit growths
Wish upon on a star
Narendra Modi's massive electoral mandate has unfortunately raised expectations; both from the man on the street as well as from…
Bharat Biotech donates REGEN-D to victims of AP gas explosion
Donates 500 tubes of REGEN-D to AP Chief Minister’s Relief Fund
PWC’s budget expectations
'Allow tax holiday for a period of 10 year indigenously developed biopharma drugs'- Sujay Shetty, Leader - Pharma and Life…
Actavis completes Forest Laboratories acquisition
Creates an innovative new model in specialty pharmaceuticals leadership
Conference on ‘Innovations in Oral Drug Delivery Systems’ held in Mumbai
Organised by Infinity Business Services and supported by I3R Global, the conference aimed to highlight the latest trends and…
GSK and Save the Children offer $1 million award for healthcare innovations
Aims to save the lives of a million of the world’s poorest children in developing countries